| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/24/2006 | CA2598381A1 Replikin peptides and uses thereof |
| 08/24/2006 | CA2598359A1 Plant cyclopropane fatty acid synthase genes and uses thereof |
| 08/24/2006 | CA2598292A1 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
| 08/24/2006 | CA2597958A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 08/24/2006 | CA2597903A1 Cationic lipids for the transfection of nucleic acids |
| 08/24/2006 | CA2597889A1 Aptamer therapeutics useful in the treatment of complement-related disorders |
| 08/24/2006 | CA2597837A1 Tissue specific expression of antibodies in chickens |
| 08/24/2006 | CA2597816A1 Compounds |
| 08/24/2006 | CA2597708A1 Metabolic-based methods for modulating gene expression |
| 08/24/2006 | CA2597655A1 Flavivirus replicon constructs for tumour therapy |
| 08/24/2006 | CA2597319A1 Sample preparation method incorporating an alkaline shock |
| 08/24/2006 | CA2597020A1 Inhibitor peptides |
| 08/24/2006 | CA2596509A1 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 08/24/2006 | CA2572151A1 Oligonucleotides comprising a non-phosphate backbone linkage |
| 08/23/2006 | EP1693670A1 Reaction vessel and reaction device using the same, detection device and reaction vessel producing method |
| 08/23/2006 | EP1693465A1 Method of examining chemical using gene-disrupted strain |
| 08/23/2006 | EP1693460A1 Method of regulating heterologous protein expression controlled by salicylic derivatives in micro-organisms associated with higher organisms |
| 08/23/2006 | EP1693459A1 Chimeric type 5/type 11 or type 35 adenovirus vector for preventing infection with antihuman immunodeficiency virus |
| 08/23/2006 | EP1693458A1 Intracellular inhibitory peptides |
| 08/23/2006 | EP1693457A2 Metastatic breast and colon cancer regulated genes |
| 08/23/2006 | EP1693456A1 Gene encoding g protein-coupled receptor and gene product thereof |
| 08/23/2006 | EP1693455A1 Simian orl1 gene and method of assessing compound |
| 08/23/2006 | EP1693454A1 Apparatus for extracting nucleic acid |
| 08/23/2006 | EP1693453A1 Process for separating single-stranded from double-stranded nucleic acids and the separation column for carrying out this process |
| 08/23/2006 | EP1693452A1 Method of estimating toxicity of drug |
| 08/23/2006 | EP1693451A1 Method of growing myocardial cells |
| 08/23/2006 | EP1693450A1 METHOD OF EVALUATING RNAi ACTIVITY AND miRNA ACTIVITY |
| 08/23/2006 | EP1693449A1 Cell-free notch cleavage analysis method and drug screening method |
| 08/23/2006 | EP1693448A1 Double specific antibodies substituting for functional protein |
| 08/23/2006 | EP1693444A1 Substance injecting apparatus |
| 08/23/2006 | EP1693386A1 Methods for producing antibody |
| 08/23/2006 | EP1693385A1 Humanized anti-cd47 antibody |
| 08/23/2006 | EP1693384A2 Functional immunoglobulins against human serum albumin, fragments thereof, library thereof and methods of production thereof |
| 08/23/2006 | EP1693382A2 Melanocortin 1 receptor selective compounds |
| 08/23/2006 | EP1693381A1 Glycine-rich proteins, their coding sequences and applications |
| 08/23/2006 | EP1693380A2 Nucleic acid sequence encoding the OPCA gene |
| 08/23/2006 | EP1693379A1 Protein nmb0928 and use thereof in pharmaceutical formulations |
| 08/23/2006 | EP1693378A2 Protein nmb1125 and use thereof in pharmaceutical formulations |
| 08/23/2006 | EP1693070A1 Procaspase 1 activation inhibitor |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1693066A2 Immortalized human keratinocyte cell line |
| 08/23/2006 | EP1693062A2 Androgen receptor-dependent gene expression control |
| 08/23/2006 | EP1692936A1 Method for targeted conditional DNA recombination in mice using the cre-ert2 fusion protein |
| 08/23/2006 | EP1692518A2 Detection of protein interactions |
| 08/23/2006 | EP1692486A2 Biosensors for detecting macromolecules and other analytes |
| 08/23/2006 | EP1692308A2 Genetic reference materials |
| 08/23/2006 | EP1692303A2 Clp-protease as target for herbicides |
| 08/23/2006 | EP1692294A2 Vectors, mutant viruses and methods for generating mutant viruses |
| 08/23/2006 | EP1692293A2 Adenovirus-transfected primary cells and methods of pathway mapping |
| 08/23/2006 | EP1692292A1 Transgenic disease resistant banana |
| 08/23/2006 | EP1692291A2 System for the inducible expression of recombinant proteins in cyanobacteria |
| 08/23/2006 | EP1692290A2 Dna cloning vector plasmids and methods for their use |
| 08/23/2006 | EP1692289A1 Rice and products thereof having starch with an increased proportion of amylose |
| 08/23/2006 | EP1692288A1 A novel l-threonine importer from corynebacterium and a preparation method of a strain producing l-threonine |
| 08/23/2006 | EP1692287A1 Bacterial virulence factors and uses thereof |
| 08/23/2006 | EP1692286A1 Ice recrystallisation inhibition protein or antifreeze proteins from deschampsia, lolium and festuca species of grass |
| 08/23/2006 | EP1692285A1 Methods and means for altering fiber characteristics in fiber-producing plants |
| 08/23/2006 | EP1692284A1 Anti-apoptotically active apatamers |
| 08/23/2006 | EP1692283A2 Variable valve apparatus and methods |
| 08/23/2006 | EP1692282A1 Improved protein expression systems |
| 08/23/2006 | EP1692271A1 Novel rumen bacteria variants and process for preparing succinic acid employing the same |
| 08/23/2006 | EP1692270A1 A microorganism producing 5 -xanthylic acid |
| 08/23/2006 | EP1692263A2 Compositions, methods and detection technologies for reiterative oligonucleotide synthesis |
| 08/23/2006 | EP1692262A2 METHOD OF DESIGNING siRNAS FOR GENE SILENCING |
| 08/23/2006 | EP1692186A1 Cancer cell targeting gene delivery method |
| 08/23/2006 | EP1692183A2 Chimeric anti cd44 antibodies and their use for treating acute myeloid leukemia |
| 08/23/2006 | EP1692179A1 An antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same |
| 08/23/2006 | EP1692176A1 Anti-igf-i receptor antibody |
| 08/23/2006 | EP1692174A2 Monkey immunoglobulin sequences |
| 08/23/2006 | EP1692167A2 Mutant lrp5/6 wnt-signaling receptors in cancer diagnosis, prognosis and treatment |
| 08/23/2006 | EP1692166A1 Novel muscle growth regulator |
| 08/23/2006 | EP1692165A1 High troughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein |
| 08/23/2006 | EP1692162A2 Tool for the transfer and production of proteins using the pseudomonas type iii secretion system |
| 08/23/2006 | EP1692161A2 Chimeric chemokine receptor polypeptides |
| 08/23/2006 | EP1692160A2 Fgf-5 binding and supported peptides |
| 08/23/2006 | EP1692159A2 Tgf-beta binding and supported peptides |
| 08/23/2006 | EP1692158A2 Tgf-beta binding and supported peptides |
| 08/23/2006 | EP1692156A2 Self-assembling split-fluorescent protein systems |
| 08/23/2006 | EP1692155A2 System and methods for nucleic acid and polypeptide selection |
| 08/23/2006 | EP1692154A1 Reduction of dermal scarring |
| 08/23/2006 | EP1692153A2 Inhibition of syk kinase expression |
| 08/23/2006 | EP1692152A1 Improvements in or relating to polynucleotide arrays |
| 08/23/2006 | EP1691844A1 Methods and compositions for treatment of interferon-resistant tumors |
| 08/23/2006 | EP1691843A1 Ocular tissue modification |
| 08/23/2006 | EP1691842A1 Treatment of proliferative diseases using an antisense iap oligomer and chemotherapeutic agent |
| 08/23/2006 | EP1691822A2 High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers |
| 08/23/2006 | EP1691817A2 NF-kB OLIGONUCLEOTIDE DECOY MOLECULES |
| 08/23/2006 | EP1691792A2 Compositions and methods for in vitro sorting of molecular and cellular libraries |
| 08/23/2006 | EP1691780A2 Gene delivery mediated by liposome-dna complex with cleavable peg surface modification |
| 08/23/2006 | EP1691765A2 An oncolytic adenovirus |
| 08/23/2006 | EP1691763A2 Cab molecules |
| 08/23/2006 | EP1691600A2 Tomatoes having altered acid invertase activity due to non-transgenic alterations in acid invertase genes |
| 08/23/2006 | EP1631583A4 Extracting and purifying enzymes |
| 08/23/2006 | EP1532261A4 Methods and dna constructs for high yield production of polypeptides |
| 08/23/2006 | EP1461456A4 Methods for the identification of genetic features for complex genetics classifiers |
| 08/23/2006 | EP1418803A4 Alteration of embryo/endosperm size during seed development |
| 08/23/2006 | EP1399457A4 Processes of purifying oligonucleotides |
| 08/23/2006 | EP1385949B1 Method for producing gene libraries |
| 08/23/2006 | EP1383603B1 Method for accelaration and intensification of target-receptor binding and device therefor |
| 08/23/2006 | EP1379852B1 Multi-format sample processing devices, methods and systems |